New Wosulin 30/70 100IU/ml Injection 3ml
Marketer
Wockhardt Ltd
Salt Composition
Insulin Isophane (70%) + Human insulin (30%)
Overview New Wosulin 30/70 100IU/ml Injection 3ml
Diabetics, both adult and pediatric, can benefit from InsulComb 30/70 (100 IU/ml, 3ml), a dual-action insulin injection combining short- and intermediate-acting formulations. This medication aids in glycemic management for type 1 and type 2 diabetes mellitus, typically used in conjunction with other antidiabetic therapies. Administered subcutaneously, usually 15 minutes pre-meal or within 20 minutes post-meal initiation, as directed by your healthcare provider, InsulComb 30/70 is a crucial component of a comprehensive diabetes management plan. This plan must include a balanced diet, regular physical activity, and weight management strategies as recommended by your physician. Consistent blood glucose monitoring and result reporting are vital for dose optimization. Hypoglycemia (low blood sugar) is a frequent side effect; preventive measures include accurate dosing, regular meals, and diligent blood sugar tracking. Alcohol consumption should be moderated to avoid hypoglycemic episodes. Injection site reactions (redness, swelling) and weight gain are possible. Less common side effects include rash, edema, and pruritus. Do not use InsulComb 30/70 if you have hypoglycemia. Prior to treatment, patients with kidney, liver, or heart conditions, as well as pregnant or breastfeeding individuals, must consult their physician to determine appropriate dosage adjustments.
Primary Ingredients of New Wosulin 30/70 100IU/ml Injection 3ml
No text provided to rephrase.
Uses of New Wosulin 30/70 100IU/ml Injection 3ml
Managing Diabetes
Major Benefits of New Wosulin 30/70 100IU/ml Injection 3ml:
This medication will be administered by your physician or registered nurse. Home administration instructions will be provided to you or your caregiver, as appropriate.
Common Side effects of New Wosulin 30/70 100IU/ml Injection 3ml:
- Hypoglycemia (low blood glucose level)
- Injection site reactions (pain, swelling, redness)
- Weight gain
How to use New Wosulin 30/70 100IU/ml Injection 3ml:
This medication will be administered by your physician or registered nurse. Home administration will be instructed to you or your designated caregiver.
How New Wosulin 30/70 100IU/ml Injection 3ml works:
Isophane insulin provides sustained glucose management, whereas regular human insulin offers a swift onset. Their combined effect achieves rapid and stable blood sugar levels through enhanced glucose uptake by muscle and adipose tissue, and reduced hepatic glucose output.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using New Wosulin 30/70 100IU/ml Injection 3ml is inadvisable.
PregnancySAFE IF PRESCRIBED
The injectable medication, Wosulin 30/70 100 IU/ml (3ml), is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
Lactating individuals can safely use the injectable formulation of Wosulin 30/70 (100 IU/mL, 3 mL). Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using New Wosulin 30/70 100 IU/ml Injection (3ml). Dosage modification of New Wosulin 30/70 100 IU/ml Injection (3ml) may be necessary. Physician consultation is advised. Consistent blood glucose level checks are recommended to guide dosage adjustments.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using New Wosulin 30/70 100IU/ml Injection (3ml). Dosage modification of New Wosulin 30/70 100IU/ml Injection (3ml) might be necessary. Physician consultation is advised. Routine blood glucose monitoring is recommended to guide dosage adjustments.
What if you forget to take New Wosulin 30/70 100IU/ml Injection 3ml :
Omitting a scheduled dose of New Wosulin 30/70 100IU/ml Injection 3ml can lead to elevated blood glucose (hyperglycemia). Monitor your blood sugar; adjust subsequent dosing as needed.
Facts to Know About New Wosulin 30/70 100IU/ml Injection 3ml
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently